| Name | Title | Contact Details |
|---|
West Coast Community Bank is a full-service community bank headquartered in Santa Cruz, California, serving Monterey, San Luis Obispo, Santa Clara, and Santa Cruz counties since 2004. The bank is dedicated to community involvement, actively supporting local well-being through participation and donations to regional nonprofit organizations. In 2024, it merged with 1st Capital Bancorp to enhance its capabilities and better serve the community, with plans to rebrand all branches as West Coast Community Bank by 2025. The bank offers a variety of financial services for both businesses and individuals. These include business loans, commercial real estate financing, asset-based lending, construction lending, and agricultural loans. It also provides SBA and USDA government guaranteed loans, credit cards, merchant services, and digital banking solutions. For personal banking, West Coast Community Bank offers competitive deposit solutions and consumer banking services. The bank is recognized as a leading SBA lender in Santa Cruz County and Silicon Valley, reflecting its strong support for local businesses.
SCC was originally founded in 2006, and initially conceived as a direct marketing arm for dealerships. Distinguishing itself by offering premium plans directly to consumers underwritten by A-rated insurers, SCC helps car owners find the right vehicle protection plans within their budget. Our VSC (Vehicle Service Contract) agents walk consumers through the many options available to help navigate the extended auto warranty landscape. Our mission at Secure Car Care is to help you have a better car repair experience by finding the best protection plan for you and your vehicle.
Kaufman Dolowich LLP is a nationally recognized litigation law firm that has been serving the business and insurance communities since 1986. With 13 offices across the United States, Bermuda, and the United Kingdom, the firm has expanded from a boutique labor and employment practice into a comprehensive legal service provider. It offers a wide range of services, including labor and employment law, insurance coverage and litigation, professional liability, construction law, and more. The firm is known for its client-centered approach, focusing on developing innovative and cost-effective legal strategies tailored to various industries and complex legal matters. Kaufman Dolowichs attorneys are recognized leaders in their fields, often sharing their expertise at national conferences. The firm has a diverse clientele, including businesses and insurance carriers of all sizes, and has received accolades for its workplace culture, including multiple Mansfield Certification recognitions and being named among the “Best Companies to Work For” by U.S. News & World Report.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.